Markets:

Overview

News

Currencies

International

Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

82.18 -2.86 (-3.36%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

TransMedics Targets $2B Opportunity With Kidney Push, European Expansion ↗

August 18, 2026

TransMedics Group (NASDAQ:TMDX) outlined its growth strategy at Canaccord Genuity’s 46th Annual Global Growth Conference, highlighting investments in kidney transplantation, European expansion,...

Via MarketBeat

TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX

August 17, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

TransMedics (TMDX) Q2 2026 Earnings Call Transcript ↗

August 11, 2026

Revenue hit $189.9 million with 21% growth as organ transplant volumes surge.

Via The Motley Fool

Topics Earnings

TransMedics Group (NASDAQ:TMDX) Falls as Q2 Earnings Miss Offsets Inline Revenue ↗

August 04, 2026

Via Chartmill

Topics Earnings

TransMedics Group (NASDAQ:TMDX): An Affordable Growth Stock With Strong Earnings Momentum ↗

July 28, 2026

Via Chartmill

TransMedics Group (NASDAQ:TMDX) Screens as an Affordable Growth Stock with Strong Momentum ↗

June 29, 2026

Via Chartmill

Why TransMedics Stock Is Sinking Today ↗

August 05, 2026

TransMedics stock slipped on mixed results, but its future remains bright.

Via The Motley Fool

TransMedics Group Q2 Earnings Call Highlights ↗

August 04, 2026

TransMedics Group (NASDAQ:TMDX) reported record second-quarter revenue as growth in liver procedures, clinical services and transplant logistics offset increased spending on product development,...

Via MarketBeat

Topics Earnings

TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX

August 03, 2026

From Rosen Law Firm

Via Business Wire

Where Will TransMedics Group Stock Be in 10 Years? ↗

July 03, 2026

Shares are down nearly 45%, but this healthcare innovator may be quietly building the logistics backbone of organ transplantation for decades to come.

Via The Motley Fool

TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals ↗

June 05, 2026

Via Chartmill

TransMedics Group Inc (NASDAQ:TMDX) – A Prime Example of Affordable Growth in Medical Technology ↗

May 13, 2026

Via Chartmill

3 Growth Stocks to Buy on the Dip ↗

July 02, 2026

Don't wait until they recover.

Via The Motley Fool

What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock Drop ↗

June 24, 2026

Specializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing sector challenges.

Via The Motley Fool

Topics Regulatory Compliance

3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market ↗

June 05, 2026

Credo, Cellebrite, and TransMedics are building dominant positions in huge markets with years of expansion still ahead.

Via The Motley Fool

Topics Artificial Intelligence

TransMedics Group Inc (NASDAQ:TMDX) Plunges 27% After Major Q1 Earnings Miss ↗

May 05, 2026

Via Chartmill

TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Earnings Momentum with Bullish Technical Setup ↗

March 06, 2026

Via Chartmill

TransMedics Group Inc (NASDAQ:TMDX) Surges on Strong Q4 2025 Earnings Beat ↗

February 24, 2026

Via Chartmill

TransMedics Group Inc (NASDAQ:TMDX) Presents a Strong Growth and Technical Breakout Opportunity ↗

February 21, 2026

Via Chartmill

This Healthcare Infrastructure Stock Is Risky, But the Upside Looks Huge ↗

June 02, 2026

The stock plunged, but its transplant platform may still be building a powerful moat. Is this a rare opportunity, or a margin trap?

Via The Motley Fool

My Top 3 Stocks to Buy in May ↗

May 07, 2026

Forget "sell in May and go away." These stocks are good picks to buy and hold.

Via The Motley Fool

Topics Earnings

TransMedics (TMDX) Q1 2026 Earnings Transcript ↗

May 06, 2026

TransMedics (TMDX) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics Economy

These stocks are moving in today's pre-market session ↗

May 06, 2026

Via Chartmill

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

May 05, 2026

Via Chartmill

2 Healthcare Stocks That Could Outperform the Market Over the Next Decade ↗

April 16, 2026

Both have helped transform their respective industries.

Via The Motley Fool

Another Day, Another Massive AI Infrastructure Deal ↗

March 30, 2026

The Hidden Gems team discusses the latest AI infrastructure deal between Meta Platforms and neocloud company Nebius, then delves into consumer spending via Dollar Tree's 2025 results.

Via The Motley Fool

Topics Artificial Intelligence

TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? ↗

March 08, 2026

TransMedics continues to reinvent the organ transplant industry, but the market insists the stock is "overvalued" now.

Via The Motley Fool

4 Top Stocks Long-Term Investors Should Buy in March ↗

March 08, 2026

Four dominant, cash-generating compounders just went on sale. The fundamentals say the long-term story is only getting stronger.

Via The Motley Fool

Topics Artificial Intelligence

Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot ↗

February 28, 2026

The mid-cap healthcare specialist is definitely worth a second look.

Via The Motley Fool

6 Stock Ideas for the Next 5 Years ↗

February 17, 2026

Listen in as Motley Fool co-founder Tom Gardner and Chief Investment Officer Andy Cross talk about stocks!

Via The Motley Fool

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.